ESC 365 - Heart failure with mid ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire EF spectrum.

HFA Premium Access

Heart failure with mid ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire EF spectrum.

Session: Late Breaking Trials II: Focus on chronic heart failure

Topic: Miscellaneous

Speaker: Professor L. Lund (Stockholm, SE)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

61 presentations

10 followers

11 more presentations in this session

The which heart failure intervention is most cost-effective in reducing hospital stay trial.

Speaker: Professor S. Stewart (Sydney, AU)

Discussion: The which heart failure intervention is most cost-effective in reducing hospital stay trial.

Global variations in mortality among patients with heart failure.

Speaker: Doctor H. Dokainish (Hamilton, CA)

Discussion: Global variations in mortality among patients with heart failure.

Discussion: CHARM.

Access the full session

Late Breaking Trials II: Focus on chronic heart failure

Speakers: Professor L. Lund, Professor S. Stewart, Doctor H. Dokainish

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources